Quotables
"The radio craze will die out in time."
Thomas Edison ; 1922
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110236462 | INTRAVAGINAL DRUG DELIVERY DEVICE Described herein is an intravaginal drug delivery system. In an embodiment the intravaginal drug delivery system includes a progestin and estrogen compound, and releases the active ingredients in a fixed physiological ratio over a prolonged period of time to produce a c... | 09/29/2011 |
| 20110212155 | Flexible, Compressed Intravaginal Rings, Methods of Making and Using the Same, and Apparatus for Making the Same The present invention is directed to flexible, compressed intravaginal rings comprising a substantially homogeneous compressed mixture comprising a polymethacrylate, a plasticizer, and an active agent, and methods of making and using the same, and apparatus for making t... | 09/01/2011 |
| 20110097382 | METHODS AND KITS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE AND PREGNANCY-RELATED DISORDERS IN RECIPIENTS OF ARTIFICIAL INSEMINATION Methods and kits for preventing or reducing the likelihood of implantation failure and pregnancy-related disorders in a recipient of artificial insemination are provided. The methods include administering into a recipient of artificial insemination in need of such treat... | 04/28/2011 |
| 20110033519 | Device with Aromatase Inhibitor for the Treatment and Prevention of Uterine Fibroids and Method of Use The invention provides a device and a compound for the prevention and/or treatment of uterine fibroids in human patients, wherein the compound is dispensed from the device and is administered locally to the uterine tissue.... | 02/10/2011 |
| 20110020423 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION Methods for the treatment of CNS disorders using combinations of muscarinic activators and inhibitors, and medicaments comprising muscarinic activators and inhibitors.... | 01/27/2011 |
| 20100330138 | BIOSTABLE, MULTIPURPOSE, MICROBICIDAL INTRAVAGINAL DEVICES Biostable, multipurpose, microbicidal intravaginal devices in the form of rings, ringed-meshes, sponges, or diaphragms for use by women and condoms for use by male partners are provided, wherein each of the devices contains a drug effective in treating a particular vagi... | 12/30/2010 |
| 20100285097 | VAGINAL DELIVERY SYSTEM The present invention is related to an intravaginal delivery system for the controlled release of drospirenone and an estrogen, optionally also comprising one or more therapeutically active or a health-promoting substance capable of giving and/or enhancing protection ag... | 11/11/2010 |
| 20100203104 | DELIVERY SYSTEM FOR RISPERIDONE This invention relates to an extended release formulation comprising solid risperidone, which formulation is a vaginal device having a skin and which device comprises an inner compartment made of a thermoplastic polymer, which polymer is containing risperidone. The poly... | 08/12/2010 |
| 20100136090 | Helically-Shaped Drug Delivery System The present invention relates to a helically-shaped medicated veterinary system suitable for delivery of a drug to the vaginal cavity of a female non-human mammal and to a method of manufacture. The drug delivery system is helically-shaped and comprises a three layered ... | 06/03/2010 |
| 20100129425 | VAGINAL DELIVERY SYSTEM FOR MIRTAZAPINE This invention relates to an extended release formulation comprising solid mirtazapine, which formulation is a vaginal device having a skin and which device comprises an inner compartment made of a thermoplastic polymer, which polymer is containing mirtazapine. The poly... | 05/27/2010 |
| 20100062039 | Intravaginal Ringed Mesh Device And Applicator Therefor This invention generally covers a ringed-mesh intravaginal device and applicator therefore wherein the ringed-mesh comprises a composite ring comprising a flexible matrix containing one or more bioactive agent or agents and needed excipients or modulators, and the said ... | 03/11/2010 |
| 20100040671 | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof The present invention relates to intravaginal devices having a rigid support, methods of making, and uses thereof. The devices comprise (a) a rigid support having a Shore A Hardness of at least about 20 and a tensile strength of at least about 1 MPa, (b) a matrix, and (... | 02/18/2010 |
| 20100034863 | Delivery Devices Containing Encapsulated and/or Particle-Bound Active Pharmaceutical Ingredients Delivery devices of a degradable or nondegradable biocompatible matrix with one or more encapsulated active pharmaceutical ingredients or one or more particle-bound active pharmaceutical ingredients dispersed in the matrix are provided. Also provided are methods for del... | 02/11/2010 |
| 20090324692 | Polyurethane Elastomers A linear polymer is obtained by reacting together a polyethylene glycol or polypropylene glycol; a PEG-PPG-PEG or PPG-PEG-PPG block copolymer; a difunctional amine or diol; and a diisocyanate. A controlled release composition comprises the polymer together with an activ... | 12/31/2009 |
| 20090311306 | Intrauterine contraceptive device An intrauterine contraceptive device comprising a carrier body (1) and an active metallic alloy (4), characterized in that the active metallic alloy is of the formula ZnxCuyMnzAuk (I) or ZnxCuy 12/17/2009 | |
| 20090291120 | Hydrophilic Polyurethane Compositions A water-swellable linear polymer is made by reacting together a polyethylene oxide of number average molecular weight less than 4,000, an aliphatic diol, and a difunctional diisocyanate. Controlled release composition comprises the polymer together with an active agent.... | 11/26/2009 |
| 20090246254 | NON-HORMONAL VAGINAL CONTRACEPTIVE The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present invention also relates to methods of contraception using such a device, as well a... | 10/01/2009 |
| 20090208558 | Use of Combination Preparations Comprising Antifungal Agents The invention relates to the use of an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor for producing a combination drug for the topical treatment of Candida mycoses selected from vulvovaginal candidiasis, oropharyngeal candidiasis ... | 08/20/2009 |
| 20090202612 | Monolithic Intravaginal Rings Comprising Progesterone and Methods of Making and Uses Thereof The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fat... | 08/13/2009 |
| 20090123522 | Medicament Delivery Device and a Method of Medicament Delivery A medicament delivery device and method of delivering a medicament is provided wherein the device is insertable into the uterine myometrium for the delivery of medicaments to the pelvic area and organs thereof, for example, the bladder, peritoneum, the vulva, vagina, fa... | 05/14/2009 |
| 20090060982 | METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments f... | 03/05/2009 |
| 20080286339 | METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments f... | 11/20/2008 |
| 20080206309 | ANTAGONISTS OF PROSTAGLANDIN RECEPTORS EP2 AND/OR EP4 FOR THE TREATMENT OF DYSMENORRHEA AND MENORRHAGIA A method of treating menorrhagia and/or dysmenorrhoea in a patient the method comprising administering to the patient an antagonist of a prostaglandin EP2 and/or EP4 receptor. Preferably the patient is a human female.... | 08/28/2008 |
| 20080206310 | Regimens for Controlled Drug Delivery Devices for Contraception The subject invention provides for new regimens for contraceptive dosage forms.... | 08/28/2008 |
| 20080199511 | Sustained Release Compositions Containing Progesterone Receptor Modulators Disclosed are sustained release compositions for vaginal or transdermal administration that contain a progesterone receptor modulator such as CDB-2914 (also referred to as VA-2914), and methods of using them for long term contraception or therapeutic purposes. Also disc... | 08/21/2008 |
| 20080095825 | Method for Making a Reservoir Containing an Active Substance Diffused through the Reservoir and Installation Therefor The invention concerns a method for making a reservoir (5) containing an active substance and adapted to be introduced into a natural cavity of a living being, the reservoir (5) comprising a membrane (9) permeable to the active substance. Said metho... | 04/24/2008 |
| 20080031922 | Delivery System The present invention relates to a delivery system comprising a core and a membrane encasing said core, wherein said core and mem-brane consist essentially of an elastomer composition and said core comprises at least one therapeutically active agent. The delivery system... | 02/07/2008 |
| 20070196433 | Methods and devices for the sustained release of multiple drugs The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments f... | 08/23/2007 |
| 20060167117 | Controlled release compositions A composition for controlled release of an active material such as a fragrance, sunscreen, vitamin or biocide in a product such as a hair shampoo, shower gel, another personal product such as an antiperspirant or deodorant, a household cleaning product such as a laundry... | 07/27/2006 |
